These microbial-metabolic perturbations synergistically activate NF-κB and STAT3 signaling pathways, generating a pro-inflammatory cytokine milieu (IL-6, TNF-α, IL-1β) that establishes a tumor-promoting microenvironment through autocrine and paracrine cascades. The gene discussed is IL6; the disease is neoplasm.